MedTrace Logo

Safety Study of Outpatient Treatment for Pulmonary Embolism

NCT00425542 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 343

Last updated 2010-06-11

No results posted yet for this study

Summary

The purpose of this randomized clinical trial is to determine whether outpatient treatment is as effective and safe as inpatient treatment among low-risk patients with pulmonary embolism.

Conditions

Interventions

OTHER

Outpatient care (vs traditional inpatient care)

Patients randomized to the outpatient arm are discharged from the emergency department within 24 hours after randomization. Patients randomized to the inpatient arm are admitted to the hospital and are discharged based on the decision of the managing physician at the hospital.

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • Drahomir Aujesky, MD, MSc · University of Lausanne, Switzerland

  • Donald M Yealy, MD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States
  • Belgium
  • France
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00425542 on ClinicalTrials.gov